Suchergebnisse - "van der Heijde, Désirée"

PubPharm (448)

1

Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND) : 3-year results from an open-label, randomised controlled, non-inferiority trial

enthalten in: The Lancet. Rheumatology | 2024

von Kjørholt, K. | Sundlisæter, N. | Aga, A. | +19

2

Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs : two phase 3 randomised trials (contRAst 1 and contRAst 2)

enthalten in: Annals of the rheumatic diseases | 2023

von Fleischmann, R. | van der Heijde, D. | Strand, V. | +19

3

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission : a randomised, open label, non-inferiority trial

enthalten in: Annals of the rheumatic diseases | 2023

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +16

CommentIn: Ann Intern Med. 2023 Dec;176(12):JC139. - PMID 38048575

4

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy : 1-year results from the open-label extension of a phase III study

enthalten in: Arthritis research & therapy | 2023

von Baraliakos, X. | van der Heijde, D. | Sieper, J. | +8

5

Stricter treat-to-target in RA does not result in less radiographic progression : a longitudinal analysis in RA BIODAM

enthalten in: Rheumatology (Oxford, England) | 2023

von Ramiro, S. | Landewé, R. | van der Heijde, D. | +27

CommentIn: Rheumatology (Oxford). 2023 Sep 1;62(9):2944-2945. - PMID 36916723

6

Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis : 3-year Data From the COAST Program

enthalten in: The Journal of rheumatology | 2023

von Deodhar, A. | Poddubnyy, D. | Rahman, P. | +9

ErratumIn: J Rheumatol. 2023 May;50(5):718. - PMID 37127315

7

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and Peng

enthalten in: Annals of the rheumatic diseases | 2023

von Molto, A. | van der Heijde, D. | Van den Bosch, F. | +1

CommentOn: Ann Rheum Dis. 2021 Nov;80(11):1436-1444. - PMID 33958325

8

Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial

enthalten in: RMD open | 2023

von Stal, R. | Ramiro, S. | van der Heijde, D. | +9

9

Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials

enthalten in: The Journal of rheumatology | 2023

von Kiltz, U. | van der Heijde, D. | Boonen, A. | +5

CommentIn: J Rheumatol. 2023 Jun;50(6):724-725. - PMID 37061227

10

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions : an update

enthalten in: Annals of the rheumatic diseases | 2023

von Aletaha, D. | Kerschbaumer, A. | Kastrati, K. | +41

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[45]